ArticleScientific reports2026

An MIEN1-based hexamer peptide (LA3IK) inhibits EGF-driven oncogenic signaling in prostate cancer by disrupting EGFR-ERBB2 heterodimerization.

Amit K Tripathi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.